Insulet investors urged to seek lead plaintiff status in securities fraud case
A law firm’s notice says Insulet investors with losses may apply to lead a securities-fraud class action before an Aug. 31 deadline.
A law firm has issued a notice saying Insulet Corporation investors with losses may seek to lead a securities-fraud class action over alleged misstatements and omissions about the company’s manufacturing controls.
The notice sets an Aug. 31, 2026, deadline for investors who want to ask a court to serve as lead plaintiff in the case.
According to the notice, published Aug. 10, 2026, by the Law Offices of Howard G. Smith, the complaint covers statements made between Feb. 21, 2025, and May 26, 2026. It alleges defendants made materially false and/or misleading statements and failed to disclose adverse facts about Insulet’s business, operations and prospects.
The notice says the complaint alleges Insulet’s manufacturing controls and procedures were defective. It also alleges those problems created a foreseeable heightened risk that one or more products would violate safety regulations and/or pose a risk of injury. The filing says those alleged omissions made the company’s positive statements about its business, operations and prospects materially misleading and/or without a reasonable basis.
The notice is attorney advertising and says investors need not take immediate action. It says class members may retain counsel of their choice or remain absent class members.
The firm’s notice gives potential lead plaintiffs the option to contact the Law Offices of Howard G. Smith before Aug. 31, 2026. It lists a phone number, email address, website and Bensalem, Pennsylvania, office address for the firm.
The notice does not say how Insulet responded to the allegations, and it does not describe any court decision. It serves as a solicitation for investors who believe they suffered substantial losses in Insulet stock.
Sources
Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.
Comments ()